Pharmacologically active catechol derivatives

A compound according to formula 1 1 wherein R1 and R2 independently represent hydrogen, carbamoyl which is substituted by an alkyl of 1 to 4 carbon atoms, alkylcarbonyl of 2 to 5 carbon atoms or phenyl carbonyl, X represents halogen nitro or cyano and R3 represents wherein R4 represents cyano or alk...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: POHTO, PENTTI, MAENNISTOE, PEKKA I, BAECKSTROEM, REIJO J, KAAKKOLA, SEPPO K, LINDEN, INGE-BRITT Y, KAIRISALO, PEKKA J, HONKANEN, ERKKI J, HEINOLA, KALEVI E, PIPPURI, AINO K, PYSTYNEN, JARMO J, NISSINEN, ERKKI A. O
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:A compound according to formula 1 1 wherein R1 and R2 independently represent hydrogen, carbamoyl which is substituted by an alkyl of 1 to 4 carbon atoms, alkylcarbonyl of 2 to 5 carbon atoms or phenyl carbonyl, X represents halogen nitro or cyano and R3 represents wherein R4 represents cyano or alkylcarbonyl of 2 to 5 carbon atoms and R5 represents carbamoyl which is unsubstituted or substituted with alkyl of 1 to 8 carbon atoms or which is substituted with hydroxyalkyl of 1 to 8 carbon atoms or pharmaceutically acceptable esters and salts thereof, and a pharmaceutically acceptable carrier therefor, as well as pharmaceutical compositions containing said compounds as COMT inhibitors. A compound according to formula 1 1 wherein R1 and R2 independently represent hydrogen, carbamoyl which is substituted by an alkyl of 1 to 4 carbon atoms, alkylcarbonyl of 2 to 5 carbon atoms or phenyl carbonyl, X represents halogen nitro or cyano and R3 represents wherein R4 represents cyano or alkylcarbonyl of 2 to 5 carbon atoms and R5 represents carbamoyl which is unsubstituted or substituted with alkyl of 1 to 8 carbon atoms or which is substituted with hydroxyalkyl of 1 to 8 carbon atoms or pharmaceutically acceptable esters and salts thereof, and a pharmaceutically acceptable carrier therefor, as well as pharmaceutical compositions containing said compounds as COMT inhibitors.